|
1
|
Sprung CL, Peduzzi PN, Shatney CH, Schein
RM, Wilson MF, Sheagren JN and Hinshaw LB: Impact of encephalopathy
on mortality in the sepsis syndrome. The Veterans Administration
Systemic Sepsis Cooperative Study Group. Crit Care Med. 18:801–806.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eidelman LA, Putterman D, Putterman C and
Sprung CL: The spectrum of septic encephalopathy. Definitions,
etiologies, and mortalities. JAMA. 275:470–473. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zwilling D, Huang SY, Sathyasaikumar KV,
Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J,
Andrews-Zwilling Y, Hsieh EW, et al: Kynurenine 3-monooxygenase
inhibition in blood ameliorates neurodegeneration. Cell.
145:863–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stone TW and Darlington LG: The kynurenine
pathway as a therapeutic target in cognitive and neurodegenerative
disorders. Br J Pharmacol. 169:1211–1227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao R, Kan MQ, Wang SG, Yang RH and Zhang
SG: Disrupted tryptophan metabolism induced cognitive impairment in
a mouse model of sepsis-associated encephalopathy. Inflammation.
39:550–560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moroni F, Carpenedo R, Cozzi A, Meli E,
Chiarugi A and Pellegrini-Giampietro DE: Studies on the
neuroprotective action of kynurenine mono-oxygenase inhibitors in
post-ischemic brain damage. Adv Exp Med Biol. 527:127–136. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agudelo LZ, Femenia T, Orhan F,
Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, Correia JC, Izadi
M, Bhat M, Schuppe-Koistinen I, et al: Skeletal muscle PGC-1α1
modulates kynurenine metabolism and mediates resilience to
stress-induced depression. Cell. 159:33–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ruas JL, White JP, Rao RR, Kleiner S,
Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, et
al: A PGC-1α isoform induced by resistance training regulates
skeletal muscle hypertrophy. Cell. 151:1319–1331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujita H, Yagishita N, Aratani S,
Saito-Fujita T, Morota S, Yamano Y, Hansson MJ, Inazu M, Kokuba H,
Sudo K, et al: The E3 ligase synoviolin controls body weight and
mitochondrial biogenesis through negative regulation of PGC-1β.
EMBO J. 34:1042–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kressler D, Schreiber SN, Knutti D and
Kralli A: The PGC-1-related protein PERC is a selective coactivator
of estrogen receptor alpha. J Biol Chem. 277:13918–13925. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin J, Puigserver P, Donovan J, Tarr P and
Spiegelman BM: Peroxisome proliferator-activated receptor gamma
coactivator 1beta (PGC-1beta), A novel PGC-1-related transcription
coactivator associated with host cell factor. J Biol Chem.
277:1645–1648. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scarpulla RC: Nuclear control of
respiratory gene expression in mammalian cells. J Cell Biochem.
97:673–683. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amano T, Yamasaki S, Yagishita N,
Tsuchimochi K, Shin H, Kawahara K, Aratani S, Fujita H, Zhang L,
Ikeda R, et al: Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel
pathogenic factor for arthropathy. Genes Dev. 17:2436–2449. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bianchini E, Fanin M, Mamchaoui K, Betto R
and Sandonà D: Unveiling the degradative route of the V247M
α-sarcoglycan mutant responsible for LGMD-2D. Hum Mol Genet.
23:3746–3758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hasegawa D, Fujii R, Yagishita N,
Matsumoto N, Aratani S, Izumi T, Azakami K, Nakazawa M, Fujita H,
Sato T, et al: E3 ubiquitin ligase synoviolin is involved in liver
fibrogenesis. PLoS One. 5:e135902010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Shen Y, Ding Y, Liu Y, Su D and
Liang X: Hrd1 participates in the regulation of collagen I
synthesis in renal fibrosis. Mol Cell Biochem. 386:35–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu T, Zhao F, Gao B, Tan C, Yagishita N,
Nakajima T, Wong PK, Chapman E, Fang D and Zhang DD: Hrd1
suppresses Nrf2-mediated cellular protection during liver
cirrhosis. Genes Dev. 28:708–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamasaki S, Yagishita N, Sasaki T,
Nakazawa M, Kato Y, Yamadera T, Bae E, Toriyama S, Ikeda R, Zhang
L, et al: Cytoplasmic destruction of p53 by the endoplasmic
reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J.
26:113–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buendia I, Michalska P, Navarro E, Gameiro
I, Egea J and León R: Nrf2-ARE pathway: An emerging target against
oxidative stress and neuroinflammation in neurodegenerative
diseases. Pharmacol Ther. 157:84–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen PC, Vargas MR, Pani AK, Smeyne RJ,
Johnson DA, Kan YW and Johnson JA: Nrf2-mediated neuroprotection in
the MPTP mouse model of Parkinson's disease: Critical role for the
astrocyte. Proc Natl Acad Sci USA. 106:2933–2938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Innamorato NG, Rojo AI, García-Yagüe AJ,
Yamamoto M, de Ceballos ML and Cuadrado A: The transcription factor
Nrf2 is a therapeutic target against brain inflammation. J Immunol.
181:680–689. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rittirsch D, Huber-Lang MS, Flierl MA and
Ward PA: Immunodesign of experimental sepsis by cecal ligation and
puncture. Nat Protoc. 4:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak K: ABI Prism 7700 Sequence Detection
System, User Bulletin 2PE Applied Biosystems. Foster City, CA:
1997
|
|
24
|
Chakravarti D, LaMorte VJ, Nelson MC,
Nakajima T, Schulman IG, Juguilon H, Montminy M and Evans RM: Role
of CBP/P300 in nuclear receptor signalling. Nature. 383:99–103.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujita H, Fujii R, Aratani S, Amano T,
Fukamizu A and Nakajima T: Antithetic effects of MBD2a on gene
regulation. Mol Cell Biol. 23:2645–2657. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakajima T, Fukamizu A, Takahashi J, Gage
FH, Fisher T, Blenis J and Montminy MR: The signal-dependent
coactivator CBP is a nuclear target for pp90RSK. Cell. 86:465–474.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujita H, Ohshima T, Oishi T, Aratani S,
Fujii R, Fukamizu A and Nakajima T: Relevance of nuclear
localization and functions of RNA helicase A. Int J Mol Med.
15:555–560. 2005.PubMed/NCBI
|
|
28
|
Schlittler M, Goiny M, Agudelo LZ,
Venckunas T, Brazaitis M, Skurvydas A, Kamandulis S, Ruas JL,
Erhardt S, Westerblad H and Andersson DC: Endurance exercise
increases skeletal muscle kynurenine aminotransferases and plasma
kynurenic acid in humans. Am J Physiol Cell Physiol. 310:C836–C840.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schäfer ST, Franken L, Adamzik M, Schumak
B, Scherag A, Engler A, Schönborn N, Walden J, Koch S, Baba HA, et
al: Mitochondrial DNA: An endogenous trigger for immune paralysis.
Anesthesiology. 124:923–933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Darcy CJ, Davis JS, Woodberry T, McNeil
YR, Stephens DP, Yeo TW and Anstey NM: An observational cohort
study of the kynurenine to tryptophan ratio in sepsis: Association
with impaired immune and microvascular function. PLoS One.
6:e211852011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toh ML, Gonzales G, Koenders MI, Tournadre
A, Boyle D, Lubberts E, Zhou Y, Firestein GS, van den Berg WB and
Miossec P: Role of interleukin 17 in arthritis chronicity through
survival of synoviocytes via regulation of synoviolin expression.
PLoS One. 5:e134162010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toh ML, Marotte H, Blond JL, Jhumka U,
Eljaafari A, Mougin B and Miossec P: Overexpression of synoviolin
in peripheral blood and synoviocytes from rheumatoid arthritis
patients and continued elevation in nonresponders to infliximab
treatment. Arthritis Rheum. 54:2109–2118. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Izumi T, Fujii R, Izumi T, Nakazawa M,
Yagishita N, Tsuchimochi K, Yamano Y, Sato T, Fujita H, Aratani S,
et al: Activation of synoviolin promoter in rheumatoid synovial
cells by a novel transcription complex of interleukin enhancer
binding factor 3 and GA binding protein alpha. Arthritis Rheum.
60:63–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsuchimochi K, Yagishita N, Yamasaki S,
Amano T, Kato Y, Kawahara K, Aratani S, Fujita H, Ji F, Sugiura A,
et al: Identification of a crucial site for synoviolin expression.
Mol Cell Biol. 25:7344–7356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heisler JM and O'Connor JC: Indoleamine
2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates
inflammation-induced deficit in recognition memory. Brain Behav
Immun. 50:115–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maes M, Leonard BE, Myint AM, Kubera M and
Verkerk R: The new ‘5-HT’ hypothesis of depression: Cell-mediated
immune activation induces indoleamine 2,3-dioxygenase, which leads
to lower plasma tryptophan and an increased synthesis of
detrimental tryptophan catabolites (TRYCATs), both of which
contribute to the onset of depression. Prog Neuropsychopharmacol
Biol Psychiatry. 35:702–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
